<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Development of Vaccines : From Discovery to Clinical Testing</title>
  </titleInfo>
  <name type="personal">
    <namePart>Manmohan Singh</namePart>
    <namePart type="date">1964 November 8-</namePart>
  </name>
  <name type="personal">
    <namePart>Srivasta, Indresh K.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nju</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Hoboken, N.J</placeTerm>
    </place>
    <publisher>John Wiley &amp; Sons</publisher>
    <dateIssued>©2011</dateIssued>
    <dateIssued encoding="marc">2011</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="gmd">electronic resource</form>
    <extent>1 online resource (xiii, 454 pages) : illustrations (some color)</extent>
  </physicalDescription>
  <tableOfContents>Microbial vaccines design : the reverse vaccinology approach / Roberto Rosini, Michele A. Barocchi, Rino Rappuoli -- Design and development of recombinant vaccines with viral properties / Gerd Lipowsky, Martin F. Bachmann -- Tools for vaccine design : prediction and validation of highly immunogenic and conserved class II epitopes, and development of epitope-driven vaccines / Anne S. De Groot [and others] -- Virus like-particle vaccines advantages and challenges / Ted M. Ross [and others] -- Design platforms of nanocapsules for human therapeutics or vaccines / Masaaki Kawano [and others] -- Designing immunogens for vaccine development in reference to HIV / Aemro Kassa [and others].</tableOfContents>
  <tableOfContents>Expression and purification of recombinant proteins for vaccine applications / Carlo Zambonelli, Deeann Martinez-Guzmann, and Indresh K. Srivastava -- DNA vaccines for infectious diesase / Samuel Stepenson, Manmohan Singh, Indresh K. Srivastava -- Developing stable cell lines for the production of vaccine antigens / Xiaotian Zhong [and others] -- Spectroscopy of vaccines / C. Russell Middaugh, Sangeeta B. Joshi -- Biophysical characterization of protein antigens within vaccine formulations / Padima Malyala, Derek O'Hagan, Manmohan Singh -- Structural characteristics predict the stability of HIV / Zohar Biron [and others] -- Selection of optimal adjuvants and product factors that affect vaccine immunogenicity / Wei Wang, Manmohan Singh -- Lyophilization and stabilization of vaccines / James Chesko [and others] -- Effect of buffers and stabilizers on vaccine stability and efficacy / Shireesh P. Apte, Sydney Ugwu -- Selection of final product containers / Luis Baez, Adrian Distler -- From the lab to the clinic : filing a phase I IND for an investigational vaccine / Kenneth G. Surowitz.</tableOfContents>
  <note type="statement of responsibility">edited by Manmohan Singh, Indresh K. Srivasta.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Vaccines</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drug development</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drug stability</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL</topic>
    <topic>Pharmacology</topic>
  </subject>
  <subject authority="fast">
    <topic>Drug development</topic>
  </subject>
  <subject authority="fast">
    <topic>Drug stability</topic>
  </subject>
  <subject authority="fast">
    <topic>Vaccines</topic>
  </subject>
  <subject authority="mesh">
    <topic>Vaccines</topic>
    <topic>pharmacology</topic>
  </subject>
  <subject authority="mesh">
    <topic>Drug Discovery</topic>
    <topic>methods</topic>
  </subject>
  <subject authority="mesh">
    <topic>Drug Stability</topic>
  </subject>
  <classification authority="lcc">QR189 .D48 2011</classification>
  <classification authority="ddc" edition="22">615/.372</classification>
  <classification authority="nlm">QW 805</classification>
  <relatedItem type="otherFormat" displayLabel="Print version:">
    <titleInfo>
      <title>Development of vaccines</title>
    </titleInfo>
    <originInfo>
      <publisher>Hoboken, N.J. : John Wiley &amp; Sons, ©2011</publisher>
    </originInfo>
    <identifier type="local">(DLC)  2010048282</identifier>
    <identifier type="local">(OCoLC)682072290</identifier>
  </relatedItem>
  <identifier type="isbn">9781118023648</identifier>
  <identifier type="isbn">1118023641</identifier>
  <identifier type="isbn">9781118023624</identifier>
  <identifier type="isbn">1118023625</identifier>
  <identifier type="isbn">9781118023631</identifier>
  <identifier type="isbn">1118023633</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="lccn" invalid="yes"/>
  <identifier type="stock number">10.1002/9781118023648 Wiley InterScience</identifier>
  <identifier type="stock number">E7E4375E-C1F9-4065-A07F-245F67847567 OverDrive, Inc.</identifier>
  <identifier type="uri">http://onlinelibrary.wiley.com/book/10.1002/9781118023648</identifier>
  <location>
    <url>http://onlinelibrary.wiley.com/book/10.1002/9781118023648</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">DG1</recordContentSource>
    <recordCreationDate encoding="marc">110706</recordCreationDate>
    <recordChangeDate encoding="iso8601">20171116135625.0</recordChangeDate>
    <recordIdentifier source="OCoLC">ocn739118473</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
